AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN272201500024CNORTHBOUND THERAPEUTICS, INC.
Overview
Award facts
- Net obligations
- $37.5K
- $37,500of $37.5K potential value
- Period of performance
- Apr 21, 2016 to Apr 21, 2016
- Ended
- Modifications
- 1
- Latest action Apr 21, 2016
- Contract type
- Definitive contract
- PIID HHSN272201500024C
Description of requirement
IGF::OT::IGF INHALED CLOFAZIMINE POWDER AS NOVEL TREATMENT FOR MDR-TB: FORMULATION AND PRECLINICAL EVALUATION
Dates and value
- Award date
- Signed on Aug 7, 2015
- Potential end of performance
- Apr 20, 2016
- Current value
- $37,500Base and exercised options
- Potential value (if all options are exercised)
- $37,500
Obligations by fiscal year of action
- FY2016: -$187,500 (de-obligation)
- FY2015: $225,000
Total across 2 fiscal years: $37,500
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 21, 2016. View on USAspending · Recipient on SAM.gov
Recipient
LocationOKLAHOMA CITY, OK
UEIK3LJHVE3VJ31
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyNORTHBOUND THERAPEUTICS, INC.
Business types and certifications
Women-ownedWomen-owned small business (WOSB)Minority-ownedFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
Place of performance
- Place of performance
- Oklahoma City, Oklahoma County, Oklahoma 73104-5020
- Congressional district (place of performance)
- OK-05As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN81R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH) (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 5
Solicitation and notices
- Solicitation ID
- SBIRPHS20151(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Inhaled clofazimine powder as novel treatment for mdr-tb: formulation and preclinical evaluation
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Contract financing
- Unusual progress payments or advance paymentsD
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 7, 2015Base obligation at award: $225,000
- Latest action
- Apr 21, 2016 — Terminated for convenienceModification 1; obligation change -$187,500
- Latest substantive action
- Apr 21, 2016 — Terminated for convenienceModification 1; obligation change -$187,500
- Actions by type
- Base award1
- Terminated for convenience1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$187,500
- Latest action: change in base and all options
- -$187,500
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Research program (SBIR/STTR)
- Small business innovation research program phase i actionSR1
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930